Molecules · 2012 · 37 citations · 35 references
Combinatorial ChemistryPharmaceutical ScienceNew Drug CandidatesOrganic ChemistryAnti-staphylococcal ActivityAntimicrobial ChemotherapyChemistryPharmaceutical ChemistryMolecular PharmacologyDrug LikenessAntimicrobial Drug DiscoveryBiochemistryMolecular Properties PredictionDrug ScoreAntimicrobial CompoundDrug DevelopmentNew 1,3,4-Oxadiazole DerivativesPharmacologyNatural SciencesAntimicrobial PharmacodynamicsMedicineDrug Discovery
Five new 1-(2-(5-nitrofuran-2-yl)-5-(aryl)-1,3,4-oxadiazol-3-(2H)-yl) ethanone compounds 5a-e were synthesized by cyclization of N-acylhydrazones 4a-e with acetic anhydride under reflux conditions. Their structures were fully characterized by IR, ¹H-NMR, and ¹³C-NMR. Furthermore, evaluations of the antibacterial activity of the 1,3,4-oxadiazoles 5a-e and N-acylhydrazones 4a-e showed strong activity against several strains of Staphylococcus aureus, with MICs between 4 μg/mL to 32 μg/mL. In silico studies of the parameters of Lipinski's Rule of Five, as well as the topological polar surface area (TPSA), absorption percentage (% ABS), drug likeness and drug score indicate that these compounds, especially 4a and 5d, have potential to be new drug candidates.
35
Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy et al. · Advanced Drug Delivery Reviews · 1997 · 11K citations
Development Settings, Pharmaceutical Science, Drug Target +8
Rate-Limited Steps of Human Oral Absorption and QSAR Studies
Yuan H. Zhao, Michael H. Abraham, Joelle Le et al. · Pharmaceutical Research · 2002 · 699 citations
Adnan A. Kadi, Nasser R. El‐Brollosy, Omar A. Al‐Deeb et al. · European Journal of Medicinal Chemistry · 2006 · 295 citations